What non-drainage therapies are part of hepatic hydrothorax management?

• A. Antibiotics and chemotherapy
• B. Diuretics and transjugular intrahepatic portosystemic shunt (TIPS)
• C. Radiation therapy
• D. Immunotherapy

Answer: (B)

Hepatic hydrothorax is driven by fluid buildup from portal hypertension, so effective non-drainage management focuses on reducing the factors that create and push fluid into the pleural space. Diuretics, typically spironolactone (often with a loop diuretic), plus sodium restriction, aim to mobilize and prevent fluid accumulation from the kidneys. When that pharmacologic approach isn’t enough, a transjugular intrahepatic portosystemic shunt lowers portal venous pressure, which decreases the formation of ascites and, consequently, pleural effusions.

Radiation therapy, immunotherapy, and antibiotics/chemotherapy aren’t standard non-drainage strategies for this condition. Radiation and systemic cancer therapies aren’t targeted to the pathophysiology here, and antibiotics are used only if an infection such as spontaneous bacterial empyema is present, not to manage the hydrothorax itself.